loading...| Preferred Name |
Amantadine |
|
| Synonyms |
Cerebramed PMS Amantadine |
|
| Definitions |
An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000547 |
|
| altLabel |
Cerebramed Symadine PMS-Amantadine Amantadina Juventus Amantadina Llorente Midantan Amantadin AZU AmantaHCIAZU Gen Amantadine Endantadine Symmetrel 1-Aminoadamantane Stada, Amantadin Adamantylamine Infecto Flu InfectoFlu PMSAmantadine tregor Amantadine Hydrochloride Amantadin neuraxpharm Amanta Sulfate AZU Infex Amantadine Sulfate 1 Aminoadamantane Amantadin Stada Amanta-HCI-AZU Hydrochloride, Amantadine Llorente, Amantadina Amanta HCI AZU AmantaSulfateAZU Amantadinneuraxpharm Amantadinratiopharm Gen-Amantadine Tricyclo(3.3.1.13,7)decan-1-amine Amanta-Sulfate-AZU Wiregyt AZU, Amantadin Mantadix Adekin AL, Amantadin Amantadin AL Amantadin-neuraxpharm Aman Infecto-Flu Amixx Viregyt Sulfate, Amantadine Juventus, Amantadina Amantadin ratiopharm GenAmantadine Amanta Amantadin-ratiopharm PMS Amantadine |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C1448376 C1448365 C1448366 C1448371 C0723562 C0002403 C0043191 C1448378 C1448370 C1448364 C0026055 C1448369 C1448372 C1448362 C1448363 C0042748 C1448375 C0936072 C1448374 C0947654 C1448377 C1448367 C1448361 C1448373 C1448368 C0002404 |
|
| DC |
1 |
|
| definition |
An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. |
|
| DX |
19680101 |
|
| HN |
68(65) |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
9921T5P019 M6Q1EO9TD0 0 BF4C9Z1J53 |
|
| isa |
http://purl.bioontology.org/ontology/MESH/D000978 http://purl.bioontology.org/ontology/MESH/D018712 |
|
| LT |
TRD |
|
| Machine permutation |
68 |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C067433 http://purl.bioontology.org/ontology/MESH/C007454 http://purl.bioontology.org/ontology/MESH/C034165 http://purl.bioontology.org/ontology/MESH/C007512 http://purl.bioontology.org/ontology/MESH/C012981 http://purl.bioontology.org/ontology/MESH/C085955 http://purl.bioontology.org/ontology/MESH/C005660 http://purl.bioontology.org/ontology/MESH/C070094 http://purl.bioontology.org/ontology/MESH/C006408 http://purl.bioontology.org/ontology/MESH/C119670 http://purl.bioontology.org/ontology/MESH/C071452 http://purl.bioontology.org/ontology/MESH/C026743 http://purl.bioontology.org/ontology/MESH/C026744 http://purl.bioontology.org/ontology/MESH/C036548 http://purl.bioontology.org/ontology/MESH/C044891 http://purl.bioontology.org/ontology/MESH/C049207 http://purl.bioontology.org/ontology/MESH/C034377 |
|
| MDA |
19990101 |
|
| MMR |
20160705 |
|
| MN |
D02.455.426.100.050.035 |
|
| notation |
D000547 |
|
| PA |
D000998 D000978 D018712 D015259 |
|
| prefLabel |
Amantadine |
|
| RR |
768-94-5 (Amantadine) 9921T5P019 M6Q1EO9TD0 665-66-7 (HCl) |
|
| TERMUI |
T506167 T001667 T506169 T506091 T506131 T506088 T001662 T506127 T506089 T001666 T001660 T506125 T001668 T506176 T506151 T506121 T506149 T506162 T506153 T506143 T001665 T506165 T001661 T506175 T506145 T506129 T506147 T001663 T001664 T506173 T506123 |
|
| TH |
USAN (1964) US UK NL CA FDA SRS (2014) ES UNK (19XX) INN (19XX) DE AU USP (19XX) BAN (19XX) FR IE |
|
| tui |
T109 T121 |
|
| subClassOf |